Literature DB >> 903791

The Landry-Guillain-barré syndrome. Complications, prognosis and natural history in 123 cases.

N B Löffel, L N Rossi, M Mumenthaler, J Lütschg, H P Ludin.   

Abstract

One hundred and twenty-three patients, 68 males and 55 females in whom acute polyradiculitis Guillain-Barré appeared at an age of between 1,6 and 76 years were re-examined after 0.9 to 12.3 years. The initial symptoms, the signs during the acute phase, in particular the cranial nerve signs and central nervous signs, as well as findings in the cerebrospinal fluid and complications are described. Three patients died during the acute phase. At follow-up only 57% of the patients were completely cured. In 22% motor signs, mainly distal in the lower extremities were found. Only 6 of these patients however were handicapped. Twenty-two patients had loss of one or more tendon reflexes, in general the ankle jerk. Only 6 showed very slight central nervous system signs. Eleven of 55 follow-up cases had pathological findings in needle electromyography. A disturbance of conduction velocity or distal latency was also found in several adults and children without residual clinical signs. The time span between the maximum of the initial signs and the beginning of recovery seemed to be particularly long in patients who showed residual signs on follow-up. These patients also seemed frequently to have had a severe tetraparesis in the initial phase. We could not confirm the therapeutic effect of cortisone or ACTH in our patients: amongst the 30 adults treated with cortisone 6 (20%) had residual signs at follow-up, whilst 5 (25%) of the 22 untreated ones had similar findings.

Entities:  

Mesh:

Year:  1977        PMID: 903791     DOI: 10.1016/0022-510x(77)90183-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  19 in total

1.  A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value.

Authors:  J B Winer; R A Hughes; C Osmond
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

2.  Phrenic nerve conduction time in Guillain-Barré syndrome.

Authors:  M Gourie-Devi; G R Ganapathy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-03       Impact factor: 10.154

Review 3.  Guillain-Barré syndrome in Kenya: a clinical review of 54 patients.

Authors:  M Bahemuka
Journal:  J Neurol       Date:  1988-09       Impact factor: 4.849

4.  Long term disability and social status change after Guillain-Barré syndrome.

Authors:  A Bersano; M Carpo; S Allaria; D Franciotta; A Citterio; E Nobile-Orazio
Journal:  J Neurol       Date:  2005-08-17       Impact factor: 4.849

5.  Residual health status after Guillain-Barré syndrome.

Authors:  R A Bernsen; H M Jacobs; A E de Jager; F G van der Meché
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

6.  The Guillain-Barré syndrome: clinical and electroneuromyographic studies.

Authors:  H Takeuchi; M Takahashi; J Kang; S Ueno; A Yamada; H Miki; S Tarui
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

7.  The doctor as patient: an encounter with Guillain-Bárré syndrome.

Authors:  D Bowes
Journal:  Can Med Assoc J       Date:  1984-12-01       Impact factor: 8.262

8.  Response of the axon and barrier endothelium to experimental allergic neuritis induced by autoreactive T cell lines.

Authors:  H C Powell; R R Myers; A P Mizisin; T Olee; S W Brostoff
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange.

Authors:  R P Kleyweg; F G van der Meché
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

10.  Clinical significance of serum and CSF findings in the Guillain-Barré syndrome and related disorders.

Authors:  O G Segurado; H Krüger; H G Mertens
Journal:  J Neurol       Date:  1986-08       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.